The synopsis for this grant opportunity is detailed below, following
this paragraph. This synopsis contains all of the updates to this
document that have been posted as of
11/01/2012
. If
updates have been made to the opportunity synopsis, update information
is provided below the synopsis.
If you would like to receive notifications of changes to the grant
opportunity click
send
me change notification emails
.
The only thing you need to provide for this service is your email
address. No other information is requested.
Any inconsistency between the original printed document and the disk
or electronic document shall be resolved by giving precedence to the
printed document.
Description of Modification
The purpose of this Modification 1 to DARPA-BAA-13-03, Autonomous Diagnostics to Enable Prevention and Therapeutics: Prophylactic Options to Environmental and Contagious Threats (ADEPT-PROTECT) is to make the following change to the announcement:
The following section is revised as follows:
IV.B.5.a.
Section II. Summary of Proposal
g. A single PowerPoint slide summarizing the program and effort; use the template provided as an attachment to the announcement.
Document Type:
Modification to Previous
Grants Notice
Funding Opportunity Number:
DARPA-13-03
Opportunity Category:
Discretionary
Posted Date:
Nov 01, 2012
Creation Date:
Nov 21, 2012
Original Closing Date for Applications:
Jan 15, 2013
Current Closing Date for Applications:
Jan 15, 2013
Archive Date:
Mar 15, 2013
Funding Instrument Type:
Cooperative Agreement
Grant
Other
Procurement Contract
Category of Funding Activity:
Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards:
Estimated Total Program Funding:
Award Ceiling:
Award Floor:
CFDA Number(s):
12.910
--
Research and Technology Development
Cost Sharing or Matching Requirement:
No
Eligible Applicants
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility:
Agency Name
DARPA - Defense Sciences Office
Description
DARPA is soliciting proposals for the development of nucleic acid platforms capable of in vivo host production of a transient immune prophylaxis for adults as a component of the Autonomous Diagnostics to Enable Prevention and Therapeutics (ADEPT) program.See attached DARPA-BAA-13-03.
The following files represent the modifications to this synopsis
with the changes noted within the documents. The list of files is
arranged from newest to oldest with the newest file representing the
current synopsis. Changed sections from the previous document are shown
in a light grey background.
